id	sid	eid	entity	type
dpc-4915	2	1	2025;15(1):4915 1	CARDINAL
dpc-4915	2	2	özge sevil	PERSON
dpc-4915	2	3	bakay2	GPE
dpc-4915	2	4	fatma aslı	PERSON
dpc-4915	2	5	hapa3 1	ORG
dpc-4915	2	6	turkey	GPE
dpc-4915	2	7	2	CARDINAL
dpc-4915	2	8	pamukkale university faculty of medicine	ORG
dpc-4915	2	9	denizli	GPE
dpc-4915	2	10	3	CARDINAL
dpc-4915	2	11	izmir	PERSON
dpc-4915	2	12	turkey	GPE
dpc-4915	2	13	secukinumab	PERSON
dpc-4915	2	14	karstarlı bakay	PERSON
dpc-4915	2	15	aslı hapa f. secukinumab	PERSON
dpc-4915	4	1	2025;15(1):4915	CARDINAL
dpc-4915	4	2	october 26, 2024	DATE
dpc-4915	5	1	january 2025	DATE
dpc-4915	6	1	2024	CARDINAL
dpc-4915	7	1	https://creativecommons.org/licenses/by-nc/4.0/	ORG
dpc-4915	11	1	committee2024/252	ORG
dpc-4915	12	1	turkey	GPE
dpc-4915	14	1	sec	ORG
dpc-4915	15	1	sec	ORG
dpc-4915	16	1	sec	ORG
dpc-4915	16	2	at least 3 months	DATE
dpc-4915	17	1	31	CARDINAL
dpc-4915	17	2	14	CARDINAL
dpc-4915	17	3	45.2%	PERCENT
dpc-4915	18	1	39.32 ±	PERCENT
dpc-4915	18	2	11.77 ±	MONEY
dpc-4915	18	3	7.99 years	DATE
dpc-4915	19	1	nine (29%	PERCENT
dpc-4915	19	2	10 (32.3%	PERCENT
dpc-4915	20	1	7	CARDINAL
dpc-4915	20	2	22.6%	PERCENT
dpc-4915	20	3	hurley ii	PERSON
dpc-4915	20	4	9	CARDINAL
dpc-4915	20	5	29%	PERCENT
dpc-4915	20	6	hurley iii	PERSON
dpc-4915	20	7	15	CARDINAL
dpc-4915	20	8	48.4%	PERCENT
dpc-4915	21	1	20	CARDINAL
dpc-4915	21	2	64.5%	PERCENT
dpc-4915	21	3	the third month	DATE
dpc-4915	22	1	sec	ORG
dpc-4915	22	2	9 (29%	PERCENT
dpc-4915	22	3	2	CARDINAL
dpc-4915	23	1	2025;15(1):4915	CARDINAL
dpc-4915	23	2	1	CARDINAL
dpc-4915	24	1	first	ORDINAL
dpc-4915	24	2	1	CARDINAL
dpc-4915	24	3	2	CARDINAL
dpc-4915	25	1	hs immunopathogenesis	PERSON
dpc-4915	27	1	3	CARDINAL
dpc-4915	27	2	4	CARDINAL
dpc-4915	28	1	secukinumab	PERSON
dpc-4915	28	2	sec	ORG
dpc-4915	28	3	il-17a	PRODUCT
dpc-4915	28	4	5	CARDINAL
dpc-4915	29	1	adalimumab	PERSON
dpc-4915	29	2	first	ORDINAL
dpc-4915	29	3	the european medicines	ORG
dpc-4915	29	4	ema	ORG
dpc-4915	29	5	fda	ORG
dpc-4915	29	6	sec	ORG
dpc-4915	30	1	6	CARDINAL
dpc-4915	31	1	sec	ORG
dpc-4915	31	2	hs	PERSON
dpc-4915	32	1	sec	ORG
dpc-4915	33	1	sec	ORG
dpc-4915	34	1	sec	ORG
dpc-4915	34	2	2018	DATE
dpc-4915	35	1	between 1.1.2018 and 1.3.2024 (end date	DATE
dpc-4915	36	1	age ≥18 years	DATE
dpc-4915	36	2	sec	ORG
dpc-4915	36	3	at least 3 months	DATE
dpc-4915	37	1	sec	ORG
dpc-4915	37	2	acitretin	PERSON
dpc-4915	37	3	sec	ORG
dpc-4915	38	1	8	CARDINAL
dpc-4915	39	1	sec	ORG
dpc-4915	39	2	3 months	DATE
dpc-4915	40	1	sec	ORG
dpc-4915	40	2	300	CARDINAL
dpc-4915	40	3	5 weeks	DATE
dpc-4915	42	1	23.0	CARDINAL
dpc-4915	43	1	±	CARDINAL
dpc-4915	43	2	min-max	PERSON
dpc-4915	45	1	0.05	CARDINAL
dpc-4915	46	1	31	CARDINAL
dpc-4915	46	2	sec	ORG
dpc-4915	46	3	at least 3 months	DATE
dpc-4915	46	4	14	CARDINAL
dpc-4915	46	5	45.2%	PERCENT
dpc-4915	47	1	39.32 ±	PERCENT
dpc-4915	47	2	10.26 years	DATE
dpc-4915	47	3	11.77 ±	MONEY
dpc-4915	47	4	7.99 years	DATE
dpc-4915	47	5	28.59 ± 5.83 kg/m2	MONEY
dpc-4915	48	1	thirteen	CARDINAL
dpc-4915	48	2	41.9%	PERCENT
dpc-4915	48	3	1 (	PERCENT
dpc-4915	48	4	3.2%	PERCENT
dpc-4915	49	1	35.5%	PERCENT
dpc-4915	49	2	1 (	PERCENT
dpc-4915	49	3	3.2%	PERCENT
dpc-4915	49	4	1 (	PERCENT
dpc-4915	49	5	3.2%	PERCENT
dpc-4915	49	6	1 (	PERCENT
dpc-4915	49	7	3.2%	PERCENT
dpc-4915	50	1	pyoderma gangrenosum	PERSON
dpc-4915	50	2	1	CARDINAL
dpc-4915	50	3	sec	ORG
dpc-4915	51	1	sec	ORG
dpc-4915	53	1	2025;15(1):4915 3	CARDINAL
dpc-4915	53	2	32.3%	PERCENT
dpc-4915	53	3	9.7%	PERCENT
dpc-4915	53	4	9.7%	PERCENT
dpc-4915	54	1	nine (29%	PERCENT
dpc-4915	54	2	10 (32.3%	PERCENT
dpc-4915	55	1	7	CARDINAL
dpc-4915	55	2	22.6%	PERCENT
dpc-4915	55	3	hurley ii	PERSON
dpc-4915	55	4	9	CARDINAL
dpc-4915	55	5	29%	PERCENT
dpc-4915	55	6	hurley iii	PERSON
dpc-4915	55	7	15	CARDINAL
dpc-4915	55	8	48.4%	PERCENT
dpc-4915	56	1	96.8%	PERCENT
dpc-4915	56	2	93.5%	PERCENT
dpc-4915	56	3	35.5%	PERCENT
dpc-4915	57	1	1	CARDINAL
dpc-4915	58	1	sec	ORG
dpc-4915	58	2	150	CARDINAL
dpc-4915	58	3	1	CARDINAL
dpc-4915	58	4	300	CARDINAL
dpc-4915	58	5	19	CARDINAL
dpc-4915	58	6	300 mg/14 days	DATE
dpc-4915	58	7	10	CARDINAL
dpc-4915	58	8	300	CARDINAL
dpc-4915	59	1	300 mg/14 days	DATE
dpc-4915	59	2	1	CARDINAL
dpc-4915	60	1	sec	ORG
dpc-4915	60	2	12.06 ± 10.51	MONEY
dpc-4915	60	3	3–max	TIME
dpc-4915	60	4	48) months	DATE
dpc-4915	61	1	sec	ORG
dpc-4915	61	2	12	CARDINAL
dpc-4915	61	3	38.7%	PERCENT
dpc-4915	61	4	9 (29%	PERCENT
dpc-4915	61	5	2 (	PERCENT
dpc-4915	61	6	6.5%	PERCENT
dpc-4915	62	1	hiscr	PERSON
dpc-4915	62	2	20	CARDINAL
dpc-4915	62	3	64.5%	PERCENT
dpc-4915	62	4	the third month	DATE
dpc-4915	63	1	sec	ORG
dpc-4915	63	2	9 (29%	PERCENT
dpc-4915	63	3	1 (	PERCENT
dpc-4915	63	4	3.2%	PERCENT
dpc-4915	63	5	1 (	PERCENT
dpc-4915	63	6	3.2%	PERCENT
dpc-4915	63	7	1 (	PERCENT
dpc-4915	63	8	3.2%	PERCENT
dpc-4915	64	1	pyoderma gangrenosum	PERSON
dpc-4915	64	2	one	CARDINAL
dpc-4915	65	1	48-year-old	DATE
dpc-4915	65	2	pyoderma gangrenosum	PERSON
dpc-4915	65	3	13 months	DATE
dpc-4915	65	4	sec	ORG
dpc-4915	66	1	pyoderma gangrenosum	PERSON
dpc-4915	66	2	sec	ORG
dpc-4915	68	1	0.044	TIME
dpc-4915	68	2	0.04	CARDINAL
dpc-4915	68	3	sec	ORG
dpc-4915	69	1	0.032	CARDINAL
dpc-4915	69	2	0.007	CARDINAL
dpc-4915	69	3	0.012	CARDINAL
dpc-4915	69	4	adalimumab	PERSON
dpc-4915	69	5	0.005	CARDINAL
dpc-4915	70	1	11/22	CARDINAL
dpc-4915	70	2	50%	PERCENT
dpc-4915	70	3	hiscr	GPE
dpc-4915	72	1	sec	ORG
dpc-4915	74	1	second	ORDINAL
dpc-4915	74	2	hurley	PERSON
dpc-4915	74	3	adalimumab naivety	PERSON
dpc-4915	76	1	1	CARDINAL
dpc-4915	77	1	sec	ORG
dpc-4915	78	1	hiscr	PERSON
dpc-4915	78	2	20	CARDINAL
dpc-4915	78	3	64.5%	PERCENT
dpc-4915	78	4	31	CARDINAL
dpc-4915	80	1	sec	ORG
dpc-4915	80	2	300	CARDINAL
dpc-4915	80	3	300	CARDINAL
dpc-4915	81	1	the 16th week	DATE
dpc-4915	81	2	45%	PERCENT
dpc-4915	81	3	sec	ORG
dpc-4915	81	4	300	CARDINAL
dpc-4915	81	5	weeks	DATE
dpc-4915	81	6	42%	PERCENT
dpc-4915	81	7	sec	ORG
dpc-4915	81	8	300	CARDINAL
dpc-4915	81	9	weeks	DATE
dpc-4915	81	10	34%	PERCENT
dpc-4915	82	1	42%	PERCENT
dpc-4915	82	2	sec	ORG
dpc-4915	82	3	300	CARDINAL
dpc-4915	82	4	weeks	DATE
dpc-4915	82	5	46%	PERCENT
dpc-4915	82	6	sec	ORG
dpc-4915	82	7	300	CARDINAL
dpc-4915	82	8	weeks	DATE
dpc-4915	82	9	31%	PERCENT
dpc-4915	83	1	sec	ORG
dpc-4915	84	1	sec	ORG
dpc-4915	86	1	up to week 52	DATE
dpc-4915	87	1	5	CARDINAL
dpc-4915	88	1	9	CARDINAL
dpc-4915	89	1	hurley	PERSON
dpc-4915	89	2	9	CARDINAL
dpc-4915	92	1	sec	ORG
dpc-4915	93	1	9	CARDINAL
dpc-4915	93	2	4	CARDINAL
dpc-4915	94	1	2025;15(1):4915	CARDINAL
dpc-4915	94	2	1	CARDINAL
dpc-4915	94	3	hiscr	GPE
dpc-4915	95	1	hiscr	PERSON
dpc-4915	95	2	64.5%	PERCENT
dpc-4915	95	3	35.5%	PERCENT
dpc-4915	96	1	100%	PERCENT
dpc-4915	96	2	age, years	DATE
dpc-4915	96	3	±	CARDINAL
dpc-4915	96	4	max	PERSON
dpc-4915	97	1	37.05	CARDINAL
dpc-4915	97	2	11.36	CARDINAL
dpc-4915	97	3	11	CARDINAL
dpc-4915	97	4	55	CARDINAL
dpc-4915	97	5	9	CARDINAL
dpc-4915	97	6	45	CARDINAL
dpc-4915	97	7	27.3	CARDINAL
dpc-4915	97	8	8	DATE
dpc-4915	97	9	72.7	CARDINAL
dpc-4915	97	10	0.258 14	CARDINAL
dpc-4915	97	11	45.2	CARDINAL
dpc-4915	97	12	17	CARDINAL
dpc-4915	97	13	54.8	CARDINAL
dpc-4915	97	14	±	CARDINAL
dpc-4915	97	15	65	CARDINAL
dpc-4915	97	16	±	CARDINAL
dpc-4915	97	17	11.05	CARDINAL
dpc-4915	97	18	155	CARDINAL
dpc-4915	97	19	155	CARDINAL
dpc-4915	97	20	±	CARDINAL
dpc-4915	97	21	19	CARDINAL
dpc-4915	97	22	40.8	CARDINAL
dpc-4915	98	1	13	CARDINAL
dpc-4915	98	2	65	CARDINAL
dpc-4915	98	3	35	CARDINAL
dpc-4915	98	4	4	DATE
dpc-4915	98	5	36.4	CARDINAL
dpc-4915	98	6	6	CARDINAL
dpc-4915	98	7	54.5	CARDINAL
dpc-4915	98	8	1	CARDINAL
dpc-4915	98	9	9.1	CARDINAL
dpc-4915	98	10	0.153 17	CARDINAL
dpc-4915	98	11	54.8	CARDINAL
dpc-4915	98	12	13	DATE
dpc-4915	98	13	41.9	CARDINAL
dpc-4915	98	14	1	CARDINAL
dpc-4915	98	15	3.2	CARDINAL
dpc-4915	98	16	35	CARDINAL
dpc-4915	98	17	6	CARDINAL
dpc-4915	98	18	30	CARDINAL
dpc-4915	98	19	35	CARDINAL
dpc-4915	98	20	3	CARDINAL
dpc-4915	98	21	27.3	CARDINAL
dpc-4915	98	22	8	DATE
dpc-4915	98	23	72.7	CARDINAL
dpc-4915	98	24	0.044 7	DATE
dpc-4915	98	25	22.6	CARDINAL
dpc-4915	98	26	9	CARDINAL
dpc-4915	98	27	29	CARDINAL
dpc-4915	98	28	15	DATE
dpc-4915	98	29	48.4	CARDINAL
dpc-4915	98	30	years	DATE
dpc-4915	98	31	±	CARDINAL
dpc-4915	98	32	13-51	CARDINAL
dpc-4915	98	33	years	DATE
dpc-4915	98	34	±	CARDINAL
dpc-4915	98	35	9.6 ±	QUANTITY
dpc-4915	98	36	3	CARDINAL
dpc-4915	98	37	secukinumab use, months	GPE
dpc-4915	99	1	±	CARDINAL
dpc-4915	99	2	11.75	CARDINAL
dpc-4915	99	3	3	CARDINAL
dpc-4915	99	4	sec	ORG
dpc-4915	99	5	150 mg/28days	DATE
dpc-4915	99	6	n (%)	ORG
dpc-4915	99	7	300 mg/28days	DATE
dpc-4915	99	8	n (%	ORG
dpc-4915	99	9	300	CARDINAL
dpc-4915	99	10	n (%	ORG
dpc-4915	99	11	300mg/28 days	DATE
dpc-4915	100	1	300 mg/14 days	DATE
dpc-4915	100	2	n (%) 1 (	ORG
dpc-4915	100	3	5	CARDINAL
dpc-4915	100	4	13	CARDINAL
dpc-4915	100	5	65	CARDINAL
dpc-4915	100	6	5	CARDINAL
dpc-4915	100	7	25	CARDINAL
dpc-4915	100	8	1	CARDINAL
dpc-4915	100	9	5	CARDINAL
dpc-4915	100	10	6	CARDINAL
dpc-4915	100	11	54.5	CARDINAL
dpc-4915	100	12	5	CARDINAL
dpc-4915	100	13	45.5	CARDINAL
dpc-4915	100	14	0.452 1	CARDINAL
dpc-4915	100	15	3.2	CARDINAL
dpc-4915	100	16	19	DATE
dpc-4915	100	17	61.3	CARDINAL
dpc-4915	100	18	10	CARDINAL
dpc-4915	100	19	32.3	CARDINAL
dpc-4915	100	20	1	CARDINAL
dpc-4915	100	21	3.2	CARDINAL
dpc-4915	100	22	n (%	PERCENT
dpc-4915	100	23	n (%	PERCENT
dpc-4915	100	24	1	CARDINAL
dpc-4915	100	25	5	CARDINAL
dpc-4915	100	26	19	DATE
dpc-4915	100	27	95	CARDINAL
dpc-4915	100	28	35	CARDINAL
dpc-4915	100	29	1	CARDINAL
dpc-4915	100	30	5	CARDINAL
dpc-4915	100	31	20	CARDINAL
dpc-4915	100	32	100	CARDINAL
dpc-4915	100	33	2	CARDINAL
dpc-4915	100	34	18.2	CARDINAL
dpc-4915	100	35	10	CARDINAL
dpc-4915	100	36	90.9	CARDINAL
dpc-4915	100	37	4	DATE
dpc-4915	100	38	36.4	CARDINAL
dpc-4915	100	39	3	CARDINAL
dpc-4915	100	40	27.3	CARDINAL
dpc-4915	100	41	10	CARDINAL
dpc-4915	100	42	90.9	CARDINAL
dpc-4915	100	43	0.281	CARDINAL
dpc-4915	100	44	9.7	CARDINAL
dpc-4915	100	45	29	CARDINAL
dpc-4915	100	46	93.5	CARDINAL
dpc-4915	100	47	11	CARDINAL
dpc-4915	100	48	35.5	CARDINAL
dpc-4915	100	49	4	CARDINAL
dpc-4915	100	50	12.9	CARDINAL
dpc-4915	100	51	30	CARDINAL
dpc-4915	100	52	96.8	CARDINAL
dpc-4915	100	53	n (%	ORG
dpc-4915	100	54	n (%	PERCENT
dpc-4915	100	55	n (%	ORG
dpc-4915	100	56	n (%	ORG
dpc-4915	100	57	35	CARDINAL
dpc-4915	100	58	3	CARDINAL
dpc-4915	100	59	10	CARDINAL
dpc-4915	100	60	10	CARDINAL
dpc-4915	100	61	1	CARDINAL
dpc-4915	100	62	5	CARDINAL
dpc-4915	100	63	2	CARDINAL
dpc-4915	100	64	10	CARDINAL
dpc-4915	100	65	27.3	CARDINAL
dpc-4915	100	66	2	CARDINAL
dpc-4915	100	67	18.2	CARDINAL
dpc-4915	100	68	1	CARDINAL
dpc-4915	100	69	9.1	CARDINAL
dpc-4915	100	70	1	CARDINAL
dpc-4915	100	71	9.1	CARDINAL
dpc-4915	100	72	2	CARDINAL
dpc-4915	100	73	18.2	CARDINAL
dpc-4915	100	74	1	CARDINAL
dpc-4915	100	75	9.1	CARDINAL
dpc-4915	100	76	1 0.121	CARDINAL
dpc-4915	100	77	1 10	CARDINAL
dpc-4915	100	78	32.3	CARDINAL
dpc-4915	100	79	5	CARDINAL
dpc-4915	100	80	16.1	CARDINAL
dpc-4915	100	81	3	CARDINAL
dpc-4915	100	82	9.7	CARDINAL
dpc-4915	100	83	2	CARDINAL
dpc-4915	100	84	6.5	CARDINAL
dpc-4915	100	85	11	CARDINAL
dpc-4915	100	86	35.5	CARDINAL
dpc-4915	100	87	3	CARDINAL
dpc-4915	100	88	9.7	CARDINAL
dpc-4915	100	89	3	CARDINAL
dpc-4915	100	90	9.7	CARDINAL
dpc-4915	101	1	2025;15(1):4915 5	CARDINAL
dpc-4915	101	2	64.5%	PERCENT
dpc-4915	101	3	35.5%	PERCENT
dpc-4915	101	4	100%	PERCENT
dpc-4915	101	5	n (%	PERCENT
dpc-4915	101	6	mediterranean	LOC
dpc-4915	101	7	n (%) 1 (	ORG
dpc-4915	101	8	5	CARDINAL
dpc-4915	101	9	2	CARDINAL
dpc-4915	101	10	10	CARDINAL
dpc-4915	101	11	10	CARDINAL
dpc-4915	101	12	5	CARDINAL
dpc-4915	101	13	1	CARDINAL
dpc-4915	101	14	9.1	CARDINAL
dpc-4915	101	15	1	CARDINAL
dpc-4915	101	16	3.2	CARDINAL
dpc-4915	101	17	2	CARDINAL
dpc-4915	101	18	6.5	CARDINAL
dpc-4915	101	19	2	CARDINAL
dpc-4915	101	20	6.5	CARDINAL
dpc-4915	101	21	1	CARDINAL
dpc-4915	101	22	3.2	CARDINAL
dpc-4915	101	23	3.2	CARDINAL
dpc-4915	101	24	sec	ORG
dpc-4915	101	25	n (%) 4 (	PERCENT
dpc-4915	101	26	10	CARDINAL
dpc-4915	101	27	72.7	CARDINAL
dpc-4915	101	28	1	CARDINAL
dpc-4915	101	29	9.1	CARDINAL
dpc-4915	101	30	0.007	CARDINAL
dpc-4915	101	31	38.7	CARDINAL
dpc-4915	101	32	2	CARDINAL
dpc-4915	101	33	6.5	CARDINAL
dpc-4915	101	34	9	CARDINAL
dpc-4915	101	35	29	CARDINAL
dpc-4915	101	36	adalimumab	GPE
dpc-4915	101	37	acitretin	PERSON
dpc-4915	101	38	isotretinoin	GPE
dpc-4915	101	39	n (%	PERCENT
dpc-4915	101	40	n (%	PERCENT
dpc-4915	101	41	n (%	ORG
dpc-4915	101	42	n (%) 10 (	PERCENT
dpc-4915	101	43	5	CARDINAL
dpc-4915	101	44	1	CARDINAL
dpc-4915	101	45	5	CARDINAL
dpc-4915	101	46	4	CARDINAL
dpc-4915	101	47	10	CARDINAL
dpc-4915	101	48	11	CARDINAL
dpc-4915	101	49	100	CARDINAL
dpc-4915	101	50	7	CARDINAL
dpc-4915	101	51	63.6	CARDINAL
dpc-4915	101	52	2	CARDINAL
dpc-4915	101	53	18.2	CARDINAL
dpc-4915	101	54	2	CARDINAL
dpc-4915	101	55	18.2	CARDINAL
dpc-4915	101	56	1	CARDINAL
dpc-4915	101	57	9.1	CARDINAL
dpc-4915	101	58	2	CARDINAL
dpc-4915	101	59	18.2	CARDINAL
dpc-4915	101	60	1	CARDINAL
dpc-4915	101	61	9.1	CARDINAL
dpc-4915	101	62	1	CARDINAL
dpc-4915	101	63	9.1	CARDINAL
dpc-4915	101	64	3	CARDINAL
dpc-4915	101	65	27.3	CARDINAL
dpc-4915	101	66	0.005	CARDINAL
dpc-4915	101	67	67.7	CARDINAL
dpc-4915	101	68	15	CARDINAL
dpc-4915	101	69	48.4	CARDINAL
dpc-4915	101	70	3	CARDINAL
dpc-4915	101	71	9.7	CARDINAL
dpc-4915	101	72	2	CARDINAL
dpc-4915	101	73	6.5	CARDINAL
dpc-4915	101	74	1	CARDINAL
dpc-4915	101	75	3.2	CARDINAL
dpc-4915	101	76	3	CARDINAL
dpc-4915	101	77	9.7	CARDINAL
dpc-4915	101	78	9	CARDINAL
dpc-4915	101	79	29	CARDINAL
dpc-4915	101	80	3.2	CARDINAL
dpc-4915	101	81	1	CARDINAL
dpc-4915	101	82	3.2	CARDINAL
dpc-4915	101	83	4	DATE
dpc-4915	101	84	12.9	CARDINAL
dpc-4915	101	85	5	CARDINAL
dpc-4915	101	86	16.1	CARDINAL
dpc-4915	101	87	1	CARDINAL
dpc-4915	101	88	3.2	CARDINAL
dpc-4915	101	89	9	CARDINAL
dpc-4915	101	90	11	DATE
dpc-4915	101	91	55	CARDINAL
dpc-4915	101	92	11	CARDINAL
dpc-4915	101	93	100	CARDINAL
dpc-4915	101	94	0.012 9	CARDINAL
dpc-4915	101	95	29	CARDINAL
dpc-4915	101	96	22	DATE
dpc-4915	101	97	71	CARDINAL
dpc-4915	101	98	sec	ORG
dpc-4915	101	99	19	DATE
dpc-4915	101	100	95	CARDINAL
dpc-4915	101	101	1	CARDINAL
dpc-4915	101	102	5	CARDINAL
dpc-4915	101	103	81.8	CARDINAL
dpc-4915	101	104	1	CARDINAL
dpc-4915	101	105	9.1	CARDINAL
dpc-4915	101	106	1	CARDINAL
dpc-4915	101	107	9.1	CARDINAL
dpc-4915	101	108	19	DATE
dpc-4915	101	109	61.3	CARDINAL
dpc-4915	101	110	9	CARDINAL
dpc-4915	101	111	29	CARDINAL
dpc-4915	101	112	3.2	CARDINAL
dpc-4915	101	113	1	CARDINAL
dpc-4915	101	114	3.2	CARDINAL
dpc-4915	101	115	1	CARDINAL
dpc-4915	101	116	3.2	CARDINAL
dpc-4915	101	117	sec	ORG
dpc-4915	101	118	secukinumab	PERSON
dpc-4915	102	1	300 mg/4 weeks	DATE
dpc-4915	102	2	sec	ORG
dpc-4915	103	1	six	CARDINAL
dpc-4915	103	2	nine	CARDINAL
dpc-4915	103	3	67%	PERCENT
dpc-4915	103	4	24 weeks	DATE
dpc-4915	104	1	10	CARDINAL
dpc-4915	105	1	sec	ORG
dpc-4915	105	2	9	CARDINAL
dpc-4915	105	3	300	CARDINAL
dpc-4915	105	4	11	CARDINAL
dpc-4915	105	5	300 mg/2 weeks	DATE
dpc-4915	106	1	seventy percent	PERCENT
dpc-4915	106	2	14/20	CARDINAL
dpc-4915	106	3	hiscr	GPE
dpc-4915	106	4	week 24	DATE
dpc-4915	107	1	11	CARDINAL
dpc-4915	109	1	sec	ORG
dpc-4915	109	2	20	CARDINAL
dpc-4915	109	3	300	CARDINAL
dpc-4915	110	1	hiscr	PERSON
dpc-4915	110	2	75%	PERCENT
dpc-4915	110	3	15/20	CARDINAL
dpc-4915	110	4	the 16th week	DATE
dpc-4915	111	1	sec	ORG
dpc-4915	111	2	14 months	DATE
dpc-4915	111	3	3 to 36 months	DATE
dpc-4915	112	1	1	CARDINAL
dpc-4915	113	1	hiscr	GPE
dpc-4915	116	1	two	CARDINAL
dpc-4915	116	2	3 and 5 months	DATE
dpc-4915	116	3	12	CARDINAL
dpc-4915	117	1	melgosa ramos et al	PERSON
dpc-4915	117	2	spain	GPE
dpc-4915	117	3	sec	ORG
dpc-4915	117	4	300 mg	QUANTITY
dpc-4915	117	5	14 or 28 days	DATE
dpc-4915	117	6	23	CARDINAL
dpc-4915	117	7	17/21	CARDINAL
dpc-4915	117	8	73.9%	PERCENT
dpc-4915	117	9	hiscr	GPE
dpc-4915	117	10	week 16	DATE
dpc-4915	117	11	15/21	CARDINAL
dpc-4915	117	12	71.4%	PERCENT
dpc-4915	117	13	week 24, 10/14	DATE
dpc-4915	117	14	71.4%	PERCENT
dpc-4915	117	15	week 36	DATE
dpc-4915	117	16	10/12	CARDINAL
dpc-4915	117	17	83.3%	PERCENT
dpc-4915	117	18	week 52	DATE
dpc-4915	118	1	13	CARDINAL
dpc-4915	119	1	martora et al	PERSON
dpc-4915	119	2	sec	ORG
dpc-4915	119	3	300	CARDINAL
dpc-4915	119	4	4	CARDINAL
dpc-4915	119	5	6	CARDINAL
dpc-4915	120	1	2025;15(1):4915	CARDINAL
dpc-4915	120	2	hs	PERSON
dpc-4915	120	3	24	CARDINAL
dpc-4915	122	1	32.3%	PERCENT
dpc-4915	122	2	9.7%	PERCENT
dpc-4915	122	3	9.7%	PERCENT
dpc-4915	123	1	hs	PERSON
dpc-4915	123	2	25	CARDINAL
dpc-4915	125	1	pyoderma gangrenosum	PERSON
dpc-4915	125	2	sec	ORG
dpc-4915	125	3	one	CARDINAL
dpc-4915	127	1	pyoderma gangrenosum	PERSON
dpc-4915	128	1	pyoderma gangrenosum	PERSON
dpc-4915	128	2	sec	ORG
dpc-4915	128	3	only two	CARDINAL
dpc-4915	128	4	26	CARDINAL
dpc-4915	128	5	27	CARDINAL
dpc-4915	128	6	sec	ORG
dpc-4915	128	7	28	CARDINAL
dpc-4915	129	1	sec	ORG
dpc-4915	131	1	29	CARDINAL
dpc-4915	131	2	32	DATE
dpc-4915	131	3	33	CARDINAL
dpc-4915	132	1	plasmacytoid	GPE
dpc-4915	132	2	17	CARDINAL
dpc-4915	132	3	il-17a	PRODUCT
dpc-4915	133	1	il-17a	PRODUCT
dpc-4915	134	1	34	CARDINAL
dpc-4915	136	1	hurley	PERSON
dpc-4915	137	1	sec	ORG
dpc-4915	137	2	sec	ORG
dpc-4915	138	1	1	CARDINAL
dpc-4915	138	2	goldburg sr	PERSON
dpc-4915	138	3	payette mj	PERSON
dpc-4915	139	1	j am	PERSON
dpc-4915	140	1	2020;82(5):1045	CARDINAL
dpc-4915	141	1	10.1016	CARDINAL
dpc-4915	142	1	adalimumab	PERSON
dpc-4915	142	2	17	CARDINAL
dpc-4915	142	3	adalimumab	PERSON
dpc-4915	143	1	seven	CARDINAL
dpc-4915	143	2	21	CARDINAL
dpc-4915	143	3	52 weeks	DATE
dpc-4915	144	1	14	CARDINAL
dpc-4915	144	2	52 weeks	DATE
dpc-4915	144	3	57.1%	PERCENT
dpc-4915	144	4	8/14	CARDINAL
dpc-4915	144	5	hiscr	GPE
dpc-4915	144	6	week 16	DATE
dpc-4915	144	7	71.4%	PERCENT
dpc-4915	144	8	week 52	DATE
dpc-4915	145	1	14	CARDINAL
dpc-4915	146	1	italy	GPE
dpc-4915	146	2	sec	ORG
dpc-4915	146	3	300	CARDINAL
dpc-4915	146	4	31	CARDINAL
dpc-4915	146	5	hurley ii	PERSON
dpc-4915	146	6	anti-tnf	NORP
dpc-4915	147	1	17	CARDINAL
dpc-4915	147	2	28 weeks	DATE
dpc-4915	148	1	10%	PERCENT
dpc-4915	148	2	3/31	CARDINAL
dpc-4915	148	3	week 5	DATE
dpc-4915	148	4	26%	PERCENT
dpc-4915	148	5	8/24	CARDINAL
dpc-4915	148	6	week 16	DATE
dpc-4915	148	7	41%	PERCENT
dpc-4915	148	8	7/17	CARDINAL
dpc-4915	148	9	week 28	DATE
dpc-4915	149	1	15	CARDINAL
dpc-4915	150	1	24	CARDINAL
dpc-4915	150	2	hurley ii	PERSON
dpc-4915	150	3	adalimumab	ORG
dpc-4915	150	4	sec	ORG
dpc-4915	151	1	six (25%	PERCENT
dpc-4915	152	1	3 months	DATE
dpc-4915	152	2	13	DATE
dpc-4915	152	3	56.5%	PERCENT
dpc-4915	152	4	6 months	DATE
dpc-4915	153	1	hurley stage ii	PERSON
dpc-4915	153	2	hurley iii	PERSON
dpc-4915	154	1	16	CARDINAL
dpc-4915	155	1	sec	ORG
dpc-4915	155	2	adalimumab	PERSON
dpc-4915	156	1	28	CARDINAL
dpc-4915	156	2	67	CARDINAL
dpc-4915	156	3	41.79%	PERCENT
dpc-4915	156	4	24 weeks	DATE
dpc-4915	156	5	sec	ORG
dpc-4915	157	1	sec	ORG
dpc-4915	157	2	300	CARDINAL
dpc-4915	157	3	weeks	DATE
dpc-4915	157	4	300	CARDINAL
dpc-4915	157	5	weeks	DATE
dpc-4915	158	1	sec	ORG
dpc-4915	159	1	week 24	DATE
dpc-4915	159	2	sec	ORG
dpc-4915	160	1	17	CARDINAL
dpc-4915	162	1	abu rached et al	PERSON
dpc-4915	162	2	germany	GPE
dpc-4915	162	3	13	CARDINAL
dpc-4915	162	4	42	CARDINAL
dpc-4915	162	5	41.9%	PERCENT
dpc-4915	162	6	16 weeks	DATE
dpc-4915	162	7	sec	ORG
dpc-4915	163	1	sec	ORG
dpc-4915	163	2	300 mg/4 weeks	DATE
dpc-4915	163	3	300	CARDINAL
dpc-4915	163	4	weeks	DATE
dpc-4915	164	1	6	CARDINAL
dpc-4915	164	2	14.3%	PERCENT
dpc-4915	164	3	3	CARDINAL
dpc-4915	164	4	7.1%	PERCENT
dpc-4915	165	1	years	DATE
dpc-4915	165	2	18	CARDINAL
dpc-4915	166	1	sec	ORG
dpc-4915	166	2	19-23	CARDINAL
dpc-4915	168	1	35.5%	PERCENT
dpc-4915	169	1	sec	ORG
dpc-4915	171	1	2025;15(1):4915 7	DATE
dpc-4915	171	2	52-week	DATE
dpc-4915	172	1	clin	ORG
dpc-4915	172	2	investig	GPE
dpc-4915	173	1	2024;17:159	CARDINAL
dpc-4915	174	1	10.2147	CARDINAL
dpc-4915	174	2	15	CARDINAL
dpc-4915	175	1	italian	NORP
dpc-4915	177	1	2021;35(7):e441-e2	ORG
dpc-4915	178	1	doi:10.1111	ORG
dpc-4915	179	1	roccuzzo g	PERSON
dpc-4915	179	2	repetto f	PERSON
dpc-4915	179	3	giordano s	PERSON
dpc-4915	180	1	anti-il17	NORP
dpc-4915	182	1	2024;33(7):e15140	CARDINAL
dpc-4915	182	2	10.1111	CARDINAL
dpc-4915	182	3	17	CARDINAL
dpc-4915	183	1	fernández	PERSON
dpc-4915	183	2	fernández ballesteros md	PERSON
dpc-4915	183	3	secukinumab	PERSON
dpc-4915	185	1	2024	CARDINAL
dpc-4915	186	1	10.1007/s13555024-01209-w	MONEY
dpc-4915	186	2	18	CARDINAL
dpc-4915	187	1	abu rached n	PERSON
dpc-4915	187	2	bechara fg	PERSON
dpc-4915	187	3	years	DATE
dpc-4915	188	1	clin exp	ORG
dpc-4915	189	1	2024	CARDINAL
dpc-4915	190	1	10.1093	CARDINAL
dpc-4915	190	2	19	CARDINAL
dpc-4915	191	1	napolitano m	PERSON
dpc-4915	191	2	g. secukinumab	PERSON
dpc-4915	192	1	jaad	PERSON
dpc-4915	192	2	2019;5(2):184-7	DATE
dpc-4915	192	3	10.1016	CARDINAL
dpc-4915	193	1	pmid:30740502	GPE
dpc-4915	193	2	20	CARDINAL
dpc-4915	194	1	thorlacius l	ORG
dpc-4915	194	2	theut riis p	PERSON
dpc-4915	194	3	jemec gbe	PERSON
dpc-4915	195	1	secukinumab	PERSON
dpc-4915	197	1	2018;179(1):182-5	DATE
dpc-4915	197	2	10.1111	CARDINAL
dpc-4915	197	3	21	CARDINAL
dpc-4915	198	1	fischer	ORG
dpc-4915	198	2	boehner	PERSON
dpc-4915	198	3	biedermann t	PERSON
dpc-4915	198	4	volz t.	PERSON
dpc-4915	198	5	interleukin-17a	CARDINAL
dpc-4915	200	1	2018;98(1):151	CARDINAL
dpc-4915	200	2	10.2340/00015555-2794 pmid:28902952 22	QUANTITY
dpc-4915	201	1	jørgensen ar	PERSON
dpc-4915	201	2	thomsen	PERSON
dpc-4915	202	1	36-year-old	DATE
dpc-4915	204	1	10.1155/2018/8685136	CARDINAL
dpc-4915	204	2	pmc592 6496 23	EVENT
dpc-4915	205	1	villegas-romero	PERSON
dpc-4915	205	2	valenzuela	ORG
dpc-4915	205	3	jiménez	PERSON
dpc-4915	205	4	d.	NORP
dpc-4915	206	1	actas dermosifiliogr	PERSON
dpc-4915	207	1	2020;111(8):696-8	DATE
dpc-4915	207	2	10.1016	CARDINAL
dpc-4915	207	3	24	CARDINAL
dpc-4915	208	1	kridin k	PERSON
dpc-4915	208	2	shani m	PERSON
dpc-4915	210	1	j am	PERSON
dpc-4915	211	1	2023;88(5):e231-e6	ORG
dpc-4915	212	1	10.1016	CARDINAL
dpc-4915	213	1	25	CARDINAL
dpc-4915	213	2	nguyen tv	PERSON
dpc-4915	213	3	damiani g	PERSON
dpc-4915	213	4	jemec	PERSON
dpc-4915	216	1	2021;35(1):50-61	DATE
dpc-4915	217	1	10.1111	CARDINAL
dpc-4915	217	2	26	CARDINAL
dpc-4915	218	1	avcı c	ORG
dpc-4915	218	2	akın g	PERSON
dpc-4915	218	3	lebe b. pyoderma gangrenosum	PERSON
dpc-4915	218	4	secukinumab	PERSON
dpc-4915	219	1	j dermatolog	PERSON
dpc-4915	220	1	pmid:37449310 27	DATE
dpc-4915	221	1	clemente-hernández	PERSON
dpc-4915	221	2	álvarez	PERSON
dpc-4915	221	3	muelas-rives	PERSON
dpc-4915	221	4	secukinumab	PERSON
dpc-4915	221	5	2	CARDINAL
dpc-4915	221	6	van der zee hh	PERSON
dpc-4915	223	1	2018;9:2965	DATE
dpc-4915	224	1	10.3389	CARDINAL
dpc-4915	224	2	3	CARDINAL
dpc-4915	224	3	bc	ORG
dpc-4915	224	4	john sm	PERSON
dpc-4915	224	5	chen w	PERSON
dpc-4915	224	6	plewig g. t helper 17	PERSON
dpc-4915	226	1	2018;179(2):260-72	CARDINAL
dpc-4915	227	1	10.1111	CARDINAL
dpc-4915	227	2	4	CARDINAL
dpc-4915	227	3	matusiak ł	PERSON
dpc-4915	229	1	j am	PERSON
dpc-4915	230	1	2017;76(4):670-5	CARDINAL
dpc-4915	230	2	10.1016	CARDINAL
dpc-4915	230	3	5	CARDINAL
dpc-4915	231	1	kimball ab	PERSON
dpc-4915	231	2	jemec gbe	PERSON
dpc-4915	231	3	secukinumab	PERSON
dpc-4915	231	4	week 16 and week 52	DATE
dpc-4915	231	5	two	CARDINAL
dpc-4915	231	6	3	CARDINAL
dpc-4915	232	1	lancet	ORG
dpc-4915	233	1	2023;401(10378):747-61	CARDINAL
dpc-4915	234	1	10.1016	CARDINAL
dpc-4915	234	2	6	CARDINAL
dpc-4915	235	1	novartis europharm	ORG
dpc-4915	236	1	cosentyx®	ORG
dpc-4915	236	2	secukinumab	PERSON
dpc-4915	236	3	www.ema.europa.eu/en/documents/overview/cosentyx-epar	GPE
dpc-4915	237	1	7	CARDINAL
dpc-4915	237	2	novartis europharm	ORG
dpc-4915	238	1	cosentyx®	ORG
dpc-4915	238	2	761349	DATE
dpc-4915	239	1	504s066,761349s004lbl.pdf	CARDINAL
dpc-4915	239	2	8	CARDINAL
dpc-4915	239	3	kimball ab	PERSON
dpc-4915	239	4	jemec gb	PERSON
dpc-4915	239	5	yang m	PERSON
dpc-4915	242	1	2014;171(6	CARDINAL
dpc-4915	242	2	1434-42	CARDINAL
dpc-4915	243	1	10.1111	CARDINAL
dpc-4915	243	2	9	CARDINAL
dpc-4915	244	1	zouboulis cc	PERSON
dpc-4915	244	2	secukinumab	PERSON
dpc-4915	246	1	2024;190(6):836	CARDINAL
dpc-4915	246	2	10.1093	CARDINAL
dpc-4915	246	3	38470171 10	DATE
dpc-4915	247	1	prussick l	ORG
dpc-4915	247	2	anti-interleukin-17a	NORP
dpc-4915	250	1	2019;181(3):609-11	CARDINAL
dpc-4915	251	1	10.1111	CARDINAL
dpc-4915	251	2	11	DATE
dpc-4915	252	1	secukinumab	PERSON
dpc-4915	253	1	j am	PERSON
dpc-4915	254	1	2020;82(6):1524-6	CARDINAL
dpc-4915	254	2	10.1016	CARDINAL
dpc-4915	254	3	12	CARDINAL
dpc-4915	255	1	ac	ORG
dpc-4915	255	2	bécherel pa.	PERSON
dpc-4915	255	3	20	CARDINAL
dpc-4915	257	1	2020;34(11):e750	CARDINAL
dpc-4915	258	1	10.1111/	MONEY
dpc-4915	258	2	13	CARDINAL
dpc-4915	259	1	melgosa ramos	PERSON
dpc-4915	259	2	fj	NORP
dpc-4915	259	3	garcía	GPE
dpc-4915	259	4	ruiz r	PERSON
dpc-4915	259	5	mateu puchades	ORG
dpc-4915	259	6	a. long-term	PERSON
dpc-4915	259	7	23	CARDINAL
dpc-4915	261	1	2023;37(4):e517	CARDINAL
dpc-4915	261	2	10.1111	CARDINAL
dpc-4915	261	3	36268711 14	DATE
dpc-4915	262	1	martora f	PERSON
dpc-4915	262	2	cacciapuoti s	ORG
dpc-4915	262	3	secukinumab	PERSON
dpc-4915	262	4	adalimumab	PERSON
dpc-4915	262	5	8	CARDINAL
dpc-4915	263	1	2025;15(1):4915 31	DATE
dpc-4915	264	1	jin k	PERSON
dpc-4915	264	2	akasaka e	PERSON
dpc-4915	264	3	nakano h	ORG
dpc-4915	264	4	d. pyoderma gangrenosum	PERSON
dpc-4915	264	5	adalimumab	GPE
dpc-4915	264	6	secukinumab	GPE
dpc-4915	266	1	2019;46(3):e108-e9	ORG
dpc-4915	266	2	32	CARDINAL
dpc-4915	267	1	beaussault y	PERSON
dpc-4915	268	1	adalimumab	PERSON
dpc-4915	269	1	australas j	PERSON
dpc-4915	270	1	2017;58(4):e270	CARDINAL
dpc-4915	271	1	doi:10.1111	ORG
dpc-4915	271	2	33	CARDINAL
dpc-4915	272	1	guenova e	ORG
dpc-4915	272	2	23	CARDINAL
dpc-4915	273	1	2011;147(10):1203-5	CARDINAL
dpc-4915	274	1	pmid:21680759 34	DATE
dpc-4915	274	2	french	NORP
dpc-4915	274	3	davis md	PERSON
dpc-4915	274	4	brassard a	ORG
dpc-4915	274	5	kirsner rs	PERSON
dpc-4915	275	1	pyoderma gangrenosum	PERSON
dpc-4915	276	1	j clin	PERSON
dpc-4915	277	1	2017;18(3):355-72	CARDINAL
dpc-4915	277	2	017-0251-7	CARDINAL
dpc-4915	278	1	indian	NORP
dpc-4915	279	1	2024:1-3	CARDINAL
dpc-4915	279	2	10.25259/ijdvl_329_2024 pmid: 39152828 28	CARDINAL
dpc-4915	280	1	k. pyoderma gangrenosum	PERSON
dpc-4915	280	2	secukinumab	PERSON
dpc-4915	280	3	risankizumab	PERSON
dpc-4915	281	1	clin exp	ORG
dpc-4915	282	1	1372-4	DATE
dpc-4915	282	2	10.1111	CARDINAL
dpc-4915	282	3	29	CARDINAL
dpc-4915	283	1	aj	PERSON
dpc-4915	283	2	whitley mj	PERSON
dpc-4915	283	3	ellington k	PERSON
dpc-4915	283	4	marano al	PERSON
dpc-4915	283	5	pyoderma gangrenosum	PERSON
dpc-4915	284	1	jaad	PERSON
dpc-4915	284	2	2020;6(8):731-3	CARDINAL
dpc-4915	284	3	10.1016/j.jdcr.2020.06.011 pmid:32715064	MONEY
dpc-4915	284	4	30	CARDINAL
dpc-4915	284	5	wollina u	GPE
dpc-4915	284	6	schönlebe j	GPE
dpc-4915	284	7	c. pyoderma gangrenosum	PERSON
dpc-4915	286	1	10.1111	CARDINAL
dpc-4915	286	2	31705566	CARDINAL